Boston Scientific Corporation (NYSE: BSX) stock closed at 48.22 per share at the end of the most recent trading day (a 0.58% change compared to the prior day closing price) with a volume of 9.08M shares and market capitalization of 69.31B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 38000 people. Boston Scientific Corporation CEO is Michael F. Mahoney.

The one-year performance of Boston Scientific Corporation stock is 11.83%, while year-to-date (YTD) performance is 4.21%. BSX stock has a five-year performance of 83.35%. Its 52-week range is between 34.98 and 49.22, which gives BSX stock a 52-week price range ratio of 92.98%

Boston Scientific Corporation currently has a PE ratio of 110.30, a price-to-book (PB) ratio of 3.76, a price-to-sale (PS) ratio of 6.92, a price to cashflow ratio of 55.70, a PEG ratio of 2.32, a ROA of 2.02%, a ROC of 3.66% and a ROE of 3.77%. The company’s profit margin is 5.91%, its EBITDA margin is 19.80%, and its revenue ttm is $9.44 Billion , which makes it $6.59 revenue per share.

Of the last four earnings reports from Boston Scientific Corporation, there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.44 for the next earnings report. Boston Scientific Corporation’s next earnings report date is 26th Apr 2023.

The consensus rating of Wall Street analysts for Boston Scientific Corporation is Strong Buy (1.47), with a target price of $49.61, which is +2.88% compared to the current price. The earnings rating for Boston Scientific Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Boston Scientific Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Boston Scientific Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 9.31, ATR14 : 0.84, CCI20 : 49.87, Chaikin Money Flow : 0.16, MACD : 0.38, Money Flow Index : 59.80, ROC : 2.84, RSI : 55.79, STOCH (14,3) : 66.89, STOCH RSI : 0.25, UO : 58.61, Williams %R : -33.11), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Boston Scientific Corporation in the last 12-months were: Arthur C. Butcher (Option Excercise at a value of $425 713), Arthur C. Butcher (Sold 47 538 shares of value $2 240 246 ), Daniel J. Brennan (Option Excercise at a value of $771 751), Daniel J. Brennan (Sold 113 182 shares of value $5 283 178 ), Eric Francis Yves Thepaut (Option Excercise at a value of $0), Eric Francis Yves Thepaut (Sold 35 628 shares of value $1 486 283 ), Ian T. Meredith (Sold 6 588 shares of value $287 764 ), Jeffrey B. Mirviss (Option Excercise at a value of $387 155), Jeffrey B. Mirviss (Sold 88 620 shares of value $4 095 675 ), Jodi Euerle Eddy (Sold 2 779 shares of value $125 055 ), John Bradley Sorenson (Option Excercise at a value of $0), Jonathan Monson (Option Excercise at a value of $0), Jonathan R. Monson (Option Excercise at a value of $64 450), Jonathan R. Monson (Sold 5 000 shares of value $233 315 ), Joseph M. Fitzgerald (Option Excercise at a value of $585 761), Joseph M. Fitzgerald (Sold 79 264 shares of value $3 787 234 ), Meghan Scanlon (Option Excercise at a value of $0), Michael F. Mahoney (Option Excercise at a value of $4 704 070), Michael F. Mahoney (Sold 503 310 shares of value $20 479 545 ), Nelda J. Connors (Sold 34 284 shares of value $1 478 183 ), Scott Olson (Sold 700 shares of value $31 185 ), Vance R. Brown (Option Excercise at a value of $0), Wendy Carruthers (Option Excercise at a value of $94 954), Wendy Carruthers (Sold 139 171 shares of value $5 789 872 )